Diametric Capital, LP Yumanity Therapeutics, Inc. Transaction History

Diametric Capital, LP

  • $173 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$8.3 - $12.04 $173,793 - $252,105
-20,939 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$11.27 - $19.64 $235,982 - $411,241
20,939 New
20,939 $244,000

Others Institutions Holding YMTX

# of Institutions
1
Shares Held
7
Call Options Held
0
Put Options Held
0
View Full List

About YUMANITY THERAPEUTICS, INC.

YMTX Quotes by TradingView
  • Ticker YMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,856,500
  • Description
  • Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...
More about YMTX
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email